KIR: diverse, rapidly evolving receptors of innate and adaptive immunity.

KIR genes have evolved in primates to generate a diverse family of receptors with unique structures that enable them to recognize MHC-class I molecules with locus and allele-specificity. Their combinatorial expression creates a repertoire of NK cells that surveys the expression of almost every MHC molecule independently, thus antagonizing the spread of pathogens and tumors that subvert innate and adaptive defense by selectively downregulating certain MHC class I molecules. The genes encoding KIR that recognize classical MHC molecules have diversified rapidly in human and primates; this contrasts with conservation of immunoglobulin- and lectin-like receptors for nonclassical MHC molecules. As a result of the variable KIR-gene content in the genome and the polymorphism of the HLA system, dissimilar numbers and qualities of KIR:HLA pairs function in different humans. This diversity likely contributes variability to the function of NK cells and T-lymphocytes by modulating innate and adaptive immune responses to specific challenges.

[1]  C. Melief,et al.  Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. , 1998, Journal of immunology.

[2]  Eric O Long,et al.  The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells. , 1995, Journal of immunology.

[3]  O. Mandelboim,et al.  Self and viral peptides can initiate lysis by autologous natural killer cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Coligan,et al.  Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis , 1998, The Journal of experimental medicine.

[5]  K. Smith,et al.  Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix. , 1994, Journal of immunology.

[6]  Eric O Long,et al.  A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells , 1999, The Journal of experimental medicine.

[7]  M. Y. Kim,et al.  Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors. , 1997, Journal of immunology.

[8]  D. Cosman,et al.  Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers , 1999, Immunological reviews.

[9]  J. Felsenstein CONFIDENCE LIMITS ON PHYLOGENIES: AN APPROACH USING THE BOOTSTRAP , 1985, Evolution; international journal of organic evolution.

[10]  O. Mandelboim,et al.  The human natural killer cell immune synapse. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P Parham,et al.  Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.

[12]  Eric O Long,et al.  Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells. , 1998, Journal of immunology.

[13]  M. Colonna,et al.  Organization of the leukocyte receptor cluster (LRC) on human Chromosome 19q13.4 , 1999, Mammalian Genome.

[14]  Leena Peltonen,et al.  Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts , 2000, Nature Genetics.

[15]  H Clevers,et al.  Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1. , 1999, Immunity.

[16]  A. McMichael,et al.  Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic Cells , 1999, The Journal of experimental medicine.

[17]  M. González-Escribano,et al.  Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. , 2001, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[18]  Jeon‐Han Park,et al.  Diversity of the p70 Killer Cell Inhibitory Receptor (KIR3DL) Family Members in a Single Individual , 2000, Molecules and cells.

[19]  E. Adams,et al.  Evidence for an HLA-C-like locus in the orangutan Pongo pygmaeus , 1999, Immunogenetics.

[20]  K. Smith,et al.  NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells. , 1998, Journal of immunology.

[21]  S. J. Kim,et al.  Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual. , 1999, Immunology letters.

[22]  Eric O Long,et al.  A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. , 1997, Journal of immunology.

[23]  R. Armitage,et al.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. , 2001, Immunity.

[24]  K. Parker,et al.  Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Colonna,et al.  A human killer inhibitory receptor specific for HLA-A1,2. , 1996, Journal of immunology.

[26]  A. Amoroso,et al.  Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Eric O Long,et al.  Cutting Edge: Induction of IFN-γ Production but Not Cytotoxicity by the Killer Cell Ig-Like Receptor KIR2DL4 (CD158d) in Resting NK Cells , 2001, The Journal of Immunology.

[28]  P. Parham,et al.  The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C , 1996, The Journal of experimental medicine.

[29]  J. Bowen,et al.  Surface expression of HLA-C antigen by human extravillous trophoblast. , 2000, Placenta.

[30]  Eric O Long,et al.  A disulfide‐linked natural killer cell receptor dimer has higher affinity for HLA‐C than wild‐type monomer , 2000, European journal of immunology.

[31]  D. Baltimore,et al.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. , 1999, Immunity.

[32]  F. Brodsky,et al.  Human pathogen subversion of antigen presentation , 1999, Immunological reviews.

[33]  C. Ober,et al.  HLA-G1 protein expression is not essential for fetal survival. , 1998, Placenta.

[34]  R. Biassoni,et al.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. , 2001, Annual review of immunology.

[35]  S. Le Gall,et al.  Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. , 1998, Immunity.

[36]  A. McMichael,et al.  Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. , 2000, Science.

[37]  R. Vance,et al.  Regulation of the natural killer cell receptor repertoire. , 2001, Annual review of immunology.

[38]  Eric O Long,et al.  Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. , 1998, Journal of immunology.

[39]  P. Parham,et al.  Genes encoding human killer-cell Ig-like receptors with D1 and D2 extracellular domains all contain untranslated pseudoexons encoding a third Ig-like domain , 2000, Immunogenetics.

[40]  G. Gao,et al.  Killer Cell Immunoglobulin Receptors and T Cell Receptors Bind Peptide-Major Histocompatibility Complex Class I with Distinct Thermodynamic and Kinetic Properties* , 1999, The Journal of Biological Chemistry.

[41]  John Trowsdale,et al.  Isotypic variation of novel immunoglobulin‐like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex , 1998, European journal of immunology.

[42]  M. Llano,et al.  HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Watkins,et al.  Identification of the rhesus monkey HLA-G ortholog. Mamu-G is a pseudogene. , 1996, Journal of immunology.

[44]  Eric O Long,et al.  Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. , 1995, Immunity.

[45]  P. Parham,et al.  The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor , 1995, The Journal of experimental medicine.

[46]  J. Strominger,et al.  Definition of polymorphic residues on killer Ig‐like receptor proteins which contribute to the HLA‐C binding site , 2000, European journal of immunology.

[47]  Eric O Long,et al.  Cobalt-mediated Dimerization of the Human Natural Killer Cell Inhibitory Receptor* , 2000, The Journal of Biological Chemistry.

[48]  Jonathan W. Heusel,et al.  Vital Involvement of a Natural Killer Cell Activation Receptor in Resistance to Viral Infection , 2001, Science.

[49]  J. Dorfman,et al.  Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I‐specific Ly49 receptors , 1997, Immunological reviews.

[50]  H. Ploegh,et al.  Viral subversion of the immune system. , 2000, Annual review of immunology.

[51]  Michele Cilli,et al.  p49, a putative HLA class I‐specific inhibitory NK receptor belonging to the immunoglobulin superfamily , 1998, European journal of immunology.

[52]  P. Sun,et al.  Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Strominger,et al.  Molecular analyses of the interactions between human NK receptors and their HLA ligands. , 2000, Human immunology.

[54]  D. Mager,et al.  The Ly‐49 family: genes, proteins and recognition of class I MHC , 1997, Immunological reviews.

[55]  A. Fauci,et al.  Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Kubin,et al.  A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. , 1997, Journal of immunology.

[57]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[58]  G. Ferrara,et al.  NK3-specific natural killer cells are selectively inhibited by Bw4- positive HLA alleles with isoleucine 80 , 1994, The Journal of experimental medicine.

[59]  N. Letvin,et al.  Diversity of the Killer Cell Ig-Like Receptors of Rhesus Monkeys1 2 , 2001, The Journal of Immunology.

[60]  L. Ruggeri,et al.  Natural Killer Cell–mediated Lysis of Autologous Cells Modified by Gene Therapy , 1999, The Journal of experimental medicine.

[61]  O. Mandelboim,et al.  Enhancement of Class II-Restricted T cell Responses by Costimulatory NK Receptors for Class I MHC Proteins , 1996, Science.

[62]  G. Pantaleo,et al.  A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function , 1990, The Journal of experimental medicine.

[63]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[64]  P. Parham,et al.  Conserved organization of the ILT/LIR gene family within the polymorphic human leukocyte receptor complex , 2001, Immunogenetics.

[65]  W R Mayr,et al.  Nomenclature for factors of the HLA system, 1996. , 1997, Vox sanguinis.

[66]  P. Parham,et al.  Differential Expression of Leukocyte Receptor Complex-Encoded Ig-Like Receptors Correlates with the Transition from Effector to Memory CTL1 , 2001, The Journal of Immunology.

[67]  J. Strominger,et al.  Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Eric O Long,et al.  Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[69]  E. Rosenberg,et al.  Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[70]  O. Mandelboim,et al.  The binding site of NK receptors on HLA-C molecules. , 1997, Immunity.

[71]  C. Witt,et al.  Detection of KIR2DL4 alleles by sequencing and SSCP reveals a common allele with a shortened cytoplasmic tail. , 2000, Tissue antigens.

[72]  H. Ploegh,et al.  Trophoblast Class I Major Histocompatibility Complex (MHC) Products Are Resistant to Rapid Degradation Imposed by the Human Cytomegalovirus (HCMV) Gene Products US2 and US11 , 1998, Journal of Experimental Medicine.

[73]  P. Cresswell,et al.  Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[74]  L. Moretta,et al.  Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. , 1998, Immunology today.

[75]  O. Mandelboim,et al.  Multiple receptors for HLA-G on human natural killer cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[76]  D. Watkins,et al.  Identification of a novel MHC class I gene, Mamu-AG, expressed in the placenta of a primate with an inactivated G locus. , 1997, Journal of immunology.

[77]  Eric O Long,et al.  Killer cell inhibitory receptors: diversity, specificity, and function , 1997, Immunological reviews.

[78]  Nallasivam Palanisamy,et al.  Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR 103 , 1997 .

[79]  Seung-Hwan Lee,et al.  Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily , 2001, Nature Genetics.

[80]  D. F. Barber,et al.  Inhibition of natural killer cell activation signals by killer cell immunoglobulin‐like receptors (CD158) , 2001, Immunological reviews.

[81]  Peter Parham,et al.  Gene Structure and Promoter Variation of Expressed and Nonexpressed Variants of the KIR2DL5 Gene1 2 , 2000, The Journal of Immunology.

[82]  P. Parham,et al.  NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules , 1994, The Journal of experimental medicine.

[83]  D. Stuart,et al.  Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. , 1999, Structure.

[84]  L. Boni,et al.  Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically , 2000, Journal of medical virology.

[85]  Peter Parham,et al.  Short KIR Haplotypes in Pygmy Chimpanzee (Bonobo) Resemble the Conserved Framework of Diverse Human KIR Haplotypes , 2001, The Journal of experimental medicine.

[86]  Eric O Long,et al.  Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. , 1996, Journal of immunology.

[87]  R. Biassoni,et al.  The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions , 1996, The Journal of experimental medicine.

[88]  K. Früh,et al.  A role for MHC class I down‐regulation in NK cell lysis of herpes virus‐infected cells , 2000, European journal of immunology.

[89]  M. Bonneville,et al.  Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements1 , 2001, The Journal of Immunology.

[90]  M. Colonna,et al.  Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. , 1995, Science.

[91]  Jun Wu,et al.  Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells , 1998, Nature.

[92]  Eric O Long,et al.  Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. , 1995, Immunity.

[93]  R. Brent,et al.  LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[94]  P. Parham,et al.  Killer cell receptors: keeping pace with MHC class I evolution , 1997, Immunological reviews.

[95]  J. Bowen,et al.  Recognition of trophoblast HLA class I molecules by decidual NK cell receptors--a review. , 2000, Placenta.

[96]  F. Christiansen,et al.  The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster , 2000, Immunogenetics.

[97]  P. Parham,et al.  The Repertoire of Killer Cell Ig-Like Receptor and CD94:NKG2A Receptors in T Cells: Clones Sharing Identical αβ TCR Rearrangement Express Highly Diverse Killer Cell Ig-Like Receptor Patterns1 , 2001, The Journal of Immunology.

[98]  B Dupont,et al.  NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains. , 1996, Tissue antigens.

[99]  J. Yen,et al.  Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis1 , 2000, The Journal of Immunology.

[100]  D. G. Muir,et al.  Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. , 2000, Immunity.

[101]  P. Parham,et al.  The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. , 1995, Journal of immunology.

[102]  O. Mandelboim,et al.  Recognition of HLA-Cw4 but Not HLA-Cw6 by the NK Cell Receptor Killer Cell Ig-Like Receptor Two-Domain Short Tail Number 41 , 2001, The Journal of Immunology.

[103]  F. Garrido,et al.  The HLA crossroad in tumor immunology. , 2000, Human immunology.

[104]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[105]  B. Blom,et al.  DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. , 2000, Immunity.

[106]  Arne Svejgaard,et al.  Nomenclature for Factors of the HLA System, 1994 , 1994, Human immunology.

[107]  M. Colonna Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors , 1997, Immunological reviews.

[108]  J. Dausset,et al.  HLA-G2, -G3, and -G4 Isoforms Expressed as Nonmature Cell Surface Glycoproteins Inhibit NK and Antigen-Specific CTL Cytolysis1 , 2001, The Journal of Immunology.

[109]  R. Biassoni,et al.  Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. , 2000, Immunology today.

[110]  O. Mandelboim,et al.  Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules , 1996, The Journal of experimental medicine.

[111]  M. Llano,et al.  Human cytomegalovirus and natural killer‐mediated surveillance of HLA class I expression: a paradigm of host–pathogen adaptation , 2001, Immunological reviews.

[112]  A. Selvakumar,et al.  Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual. , 1998, Tissue antigens.

[113]  Jeffrey C. Boyington,et al.  Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand , 2000, Nature.

[114]  S. Beck,et al.  Plasticity in the organization and sequences of human KIR/ILT gene families. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[115]  Michael J. Wilson,et al.  Divergent and convergent evolution of NK-cell receptors. , 2001, Trends in immunology.

[116]  Daniel J. Schaid,et al.  Major Histocompatibility Complex Class I–Recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis , 2001, The Journal of experimental medicine.

[117]  L. Lanier Turning on Natural Killer Cells , 2000, The Journal of experimental medicine.

[118]  B. Dupont,et al.  Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR), 1998. , 2008, Tissue antigens.

[119]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[120]  J. Trowsdale,et al.  Genomic organization of a human killer cell inhibitory receptor gene. , 1997, Tissue antigens.

[121]  K. Kärre How to recongnize a foreign submarine , 1997 .

[122]  Eric O Long,et al.  Binding of a soluble p70 killer cell inhibitory receptor to HLA‐B*5101: Requirement for all three p70 immunoglobulin domains , 1997, European journal of immunology.

[123]  Eric O Long,et al.  The Direct Binding of a p58 Killer Cell Inhibitory Receptor to Human Histocompatibility Leukocyte Antigen (HLA)-Cw4 Exhibits Peptide Selectivity , 1997, The Journal of experimental medicine.

[124]  C. Witt,et al.  Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. , 1999, Transplantation.

[125]  J. Bodmer,et al.  Nomenclature for Factors of the HLA System, 1994 , 1994, Human immunology.

[126]  R. Biassoni,et al.  A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation , 1996, European journal of immunology.

[127]  J. Bodmer,et al.  IMGT/HLA Database - a sequence database for the human major histocompatibility complex , 2000, Nucleic Acids Res..

[128]  E. Ciccone,et al.  Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition , 1990, The Journal of experimental medicine.

[129]  T. Mcclanahan,et al.  Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. , 1995, Journal of immunology.

[130]  D. Goodlett,et al.  HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. , 1998, Journal of immunology.

[131]  Eric O Long,et al.  Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1–HLA-Cw4 complex , 2001, Nature Immunology.

[132]  P. Parham,et al.  Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type , 1993, The Journal of experimental medicine.

[133]  J. Peña,et al.  Threonine 80 on HLA‐B27 confers protection against lysis by a group of natural killer clones , 1996, European journal of immunology.

[134]  P. Parham,et al.  Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. , 1995, Science.

[135]  É. Vivier,et al.  Multifaceted roles of MHC class I and MHC class I–like molecules in T cell activation , 2001, Nature Immunology.

[136]  M. Colonna,et al.  The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA‐G1 and HLA‐E molecules co‐expressed on target cells , 1999, European journal of immunology.

[137]  P Parham,et al.  Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. , 1997, Journal of immunology.

[138]  Eric O Long,et al.  A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705 , 1996, The Journal of experimental medicine.

[139]  L. Lanier On guard—activating NK cell receptors , 2001, Nature Immunology.

[140]  S. Tangye,et al.  2B4-mediated activation of human natural killer cells. , 2000, Molecular immunology.

[141]  R. Biassoni,et al.  Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes , 1997, Immunological reviews.

[142]  G. Trinchieri,et al.  Molecular cloning and biological characterization of NK cell activation‐inducing ligand, a counterstructure for CD48 , 1999, European journal of immunology.

[143]  Eric O Long,et al.  Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors , 1997, Nature.

[144]  C. Barnstable,et al.  Molecular structure of human histocompatibility antigens: the HLA‐C series , 1977, European journal of immunology.

[145]  William H. Carr,et al.  Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due to KIR3DL1 Gene Polymorphism1 , 2001, The Journal of Immunology.

[146]  M. Colonna,et al.  Human natural killer cell inhibitory receptors bind to HLA class I molecules , 1996, European journal of immunology.

[147]  A. Arnaiz-Villena,et al.  Primate Mhc-E and -G alleles , 1998, Immunogenetics.

[148]  J. Strominger,et al.  Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. , 1998, Immunity.

[149]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[150]  A. McMichael,et al.  HLA‐E is expressed on trophoblast and interacts with CD94 / NKG2 receptors on decidual NK cells , 2000, European journal of immunology.

[151]  R. Biassoni,et al.  Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA‐Cw4 molecules , 1997, European journal of immunology.

[152]  O. Mandelboim,et al.  Human NK cells: their ligands, receptors and functions , 1997, Immunological reviews.

[153]  P Parham,et al.  Discovery of two novel variants of KIR2DS5 reveals this gene to be a common component of human KIR 'B' haplotypes. , 2000, Tissue antigens.

[154]  D Middleton,et al.  Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. , 2000, Tissue antigens.

[155]  P. Parham,et al.  Evidence for recombination as a mechanism for KIR diversification , 1998, Immunogenetics.

[156]  P. Parham,et al.  Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA , 1995, The Journal of experimental medicine.

[157]  R. Biassoni,et al.  P49, a putative HLA-G1 specific inhibitory NK receptor belonging to the immunoglobulin Superfamily. , 1999, Journal of reproductive immunology.

[158]  W. Fanslow,et al.  ULBP1, 2, 3: novel MHC class I‐related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells , 2001, European journal of immunology.

[159]  P Parham,et al.  Human diversity in killer cell inhibitory receptor genes. , 1997, Immunity.

[160]  M. Colonna,et al.  Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex , 1998, European journal of immunology.

[161]  R. Toes,et al.  Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells , 2001, Nature Immunology.

[162]  Markus Uhrberg,et al.  KIR2DL5, a Novel Killer-Cell Receptor with a D0-D2 Configuration of Ig-Like Domains1 2 , 2000, The Journal of Immunology.

[163]  M. Degli-Esposti,et al.  Cytomegalovirus evasion of natural killer cell responses , 1999, Immunological reviews.

[164]  H. Rammensee,et al.  Human Histocompatibility Leukocyte Antigen (HLA)-G Molecules Inhibit NKAT3 Expressing Natural Killer Cells , 1997, The Journal of experimental medicine.

[165]  D. Busch,et al.  Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. , 1999, Immunity.

[166]  R. Biassoni,et al.  Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[167]  D. Watkins,et al.  Major histocompatibility complex class I genes in primates: co‐evolution with pathogens , 1999, Immunological reviews.

[168]  M. Colonna,et al.  A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.

[169]  P Parham,et al.  Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. , 2001, Tissue antigens.

[170]  J. Strominger,et al.  The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteins. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[171]  Steven G.E. Marsh,et al.  Nomenclature for factors of the HLA system , 1975 .

[172]  J. Altman,et al.  Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b , 1998, The Journal of experimental medicine.